Published in
BioMed Central, Breast Cancer Research, 1(21), 2019
DOI: 10.1186/s13058-019-1161-9
Links
Tools
A kinase inhibitor screen identifies a dual cdc7/CDK9 inhibitor to sensitise triple-negative breast cancer to EGFR-targeted therapy
Journal article published in 2019 by
Ronan P. McLaughlin,
Vera E. van der Noord,
Jichao He,
Bob van de Water 
,
Jevin Redel,
John A. Foekens,
John W. M. Martens,
Marcel Smid,
Yinghui Zhang
,
Jevin Redel,
John A. Foekens,
John W. M. Martens,
Marcel Smid,
Yinghui Zhang
This paper is made freely available by the publisher.
Full text: Download
Data provided by 